Amenorrhoea is common in women with nonalcoholic chronic liver disease, but little is known about its causes or consequences. We investigated 12 young women with nonalcoholic chronic liver disease and amenorrhoea and compared them with 11 healthy age matched controls studied in the follicular phase of the menstrual cycle. None of the patients had raised serum concentrations of follicle stimulating hormone suggesting primary gonadal failure, but the variance in serum concentrations of testosterone, oestradiol, prolactin, and luteinising hormone were significantly greater in chronic liver disease patients than control subjects (p<0.01). Seven of the 12 chronic liver disease patients had low serum luteinising hormone concentrations, and compared with controls these patients also had significantly reduced median values of oestradiol (64 pmoill), testosterone (1.1 nmolIl), and follicle stimulating hormone, and were significantly underweight as assessed by skinfold thickness measurements (all comparisons p<0.025). In the group with chronic liver disease skinfold thickness was significantly correlated with serum luteinising hormone (p<0.02). The five patients with normal serum luteinising hormone had higher median values of both oestradiol (237 pmolll) and testosterone (3.0 nmol/l) than the control subjects (oestradiol: 113 pmol/l, testosterone: 1-9 nmolIl) but were not more obese or hirsute. Amenorrhoea was unrelated to the duration or severity of liver disease. The metacarpal cortical bone area (an index of bone density) was
inversely related to the duration of amenorrhoea (p<0.02). We Hypogonadism and feminisation are well recognised complications of alcoholic cirrhosis of the liver in men. ' Gonadal dysfunction may also occur, but is less well documented, in alcoholic women. 23 There is increasing evidence that many of these endocrine disturbances arise from the effects ofalcohol per se rather than the effects of liver disease,4 but recent studies have confirmed that hypogonadism may nonetheless be a feature of chronic non-alcoholic liver disease in men. 5 Changes in plasma concentrations of sex hormones have also been described in postmenopausal women with non-alcoholic chronic liver disease.6 There are, however, very few reports examining gonadal dysfunction in younger women with non-alcoholic chronic liver disease. 7 We have recently shown that a high proportion of women with non-alcoholic chronic liver disease coming to hepatic transplantation have appreciable amenorrhoea,8 but the causes of this (Table I) .
Eleven women aged 20-33 years (mean 26.5) were recruited from hospital staff as healthy controls. None had any history of liver disease. All had regular menstruation and none was using hormonal methods of contraception. Blood samples were drawn from control subjects in the early follicular phase of the cycle. LABORATORY 
METHODS
In both chronic liver disease patients and normal controls, serum concentrations of luteinising hormone, follicle stimulating hormone, testosterone (T), oestradiol, prolactin, and sex hormone binding globulin were measured. Luteinising hormone and follicle stimulating hormone were measured by sensitive two site immunoradiometric assays (Sucrosep kits, Boots-Celltech Diagnostics Ltd, Slough) with detection limits of 0-2 U/1 and 0 3 U/1 and interassay coefficients of variance of 6% and 8%, respectively. Sex hormone binding globulin (SHBG) was measured by the method of Rosner," with interassay coefficient of variance of 9%. The oestradiol/sex hormone binding globulin molar ratio was used as an index of free oestradiol. Derived free testosterone (dfT) concentrations were estimated from the relation:
which has been shown to correlate well with measured free testosterone (T) concentrations.'2 Radiographs of the right hand were obtained in 10 of the liver disease patients for measurement of metacarpal bone density. At the mid-point of the second metacarpal the total width (TW) and the medullary width (MW) were measured by dial gauge micrometer. The proportion of the cross sectioned area occupied by cortical bone was calculated from:
(TW2_MW2)/TW2
and the results compared with published normal values. 1 
STATISTICAL ANALYSIS
Biochemical measurements in control and chronic liver disease subjects were compared initially by Student's t test, but the variance in serum concentrations of luteinising hormone, testosterone, oestradiol, and prolactin was considerably greater in the patients (all p<0.01) indicating that it was not appropriate to use the t test. We therefore elected to subdivide the chronic liver disease patients on the basis of serum luteinising hormone concentrations. Those in whom luteinising hormone concentrations were <3 U/1 were designated hypogonadotrophic (n=7) and those in whom the concentration exceeded 4 U/1 were designated normogonadotrophic (n=5). Differences among the groups were assessed by analysis of variance using the non-parametric Kruskal-Wallis test. Group values are given as the median, with upper and lower quartiles. The Wilcoxon rank method was used when only two groups were compared. Correlations were calculated by the Spearman method.
Results
The duration of amenorrhoea in the patients ranged from 0 3 to 9 years, and was not related to the known duration of liver disease or the severity as assessed by clinical and laboratory criteria ( Table I ). The greater variation found in several of the biochemical measurements in chronic liver disease patients (when compared with control subjects), suggested that this group was not uniform in its endocrine features. We therefore divided the patients into two groups on the basis of their serum luteinising hormone concentrations. In control subjects serum luteinising hormone ranged from 4-1 to 9.7 U/1. Seven chronic liver disease patients had serum LH <3 U/1 (hypogonadotrophic) and five had values > 4 U/1 (normogonadotrophic).When compared with controls these groups showed significant differences in serum concentrations of both gonadotrophins and sex steroids. The hypogonadotrophic patients had median concentrations of luteinising hormone, follicle stimulating hormone, total testosterone, and total oestradiol that were significantly (p<0 025) below the median values in control subjects, with the median oestradiol concentration (64 pmol/l) within the postmenopausal range. Although the normogonadotrophic patients had median luteinising hormone concentrations 44% greater than control subjects, in none was the value >20 U/1 and, moreover, follicle stimulating hormone concentrations were similar, thus excluding primary gonadal failure as a cause of the amenorrhoea. Median values of total testosterone and total oestradiol were 58% and 110% greater respectively in the normogonadotrophic patients than in the control subjects (Fig 1, Table  II ). Serum sex hormone binding globulin concentrations did not differ significantly between the groups, hence the median values of free sex steroid concentrations parallelled those for total hormone concentrations. In the chronic liver disease patients serum testosterone and oestradiol were significantly correlated (r,=0 69, Median serum prolactin concentrations were greatest in the normogonadotrophic patients, but the two highest individual values (1290 and 1300 mU/l) were seen in hypogonadotrophic patients. No statistically significant differences were found between either patient group and the control subjects (Table II) .
Breast development in the hypogonadotrophic patients was less than that in normogonadotrophic patients (median stage 4 v stage 5; p<0-05). Only one patient (from the normogonadotrophic group) was hirsute. Two hypogonadotrophic patients gave a recent history of weight loss (>6 kg in the six months before the study), and as a group the hypogonadotrophic patients had significantly reduced skinfold thickness (p<0025 at both sites) compared with control subjects and normogonadotrophic patients (Table II) . In the chronic liver disease patients, but not control subjects, serum luteinising hormone was positively correlated with skinfold thickness at both the triceps 1*0. (rs=0 71, p<0 02) and the subscapular (rs=0 68, p<0 025) sites (Fig 2) . The metacarpal cortical bone area was >2 SD below normal in three of the 10 chronic liver disease patients in whom it was measured. All three had serum oestradiol concentrations in the menopausal range (<120 pmol/l). There was an inverse correlation between the duration ofamenorrhoea and the metacarpal cortical area (rs=-0 73, p<002; Fig 3) .
Discussion
This study shows that no single mechanism causes amenorrhoea in young women with nonalcoholic chronic liver disease. No 
